|
1
|
Aldape K, Zadeh G, Mansouri S,
Reifenberger G and von Deimling A: Glioblastoma: Pathology,
molecular mechanisms and markers. Acta Neuropathol. 129:829–848.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanu OO, Hughes B, Di C, Lin N, Fu J,
Bigner DD, Yan H and Adamson C: Glioblastoma multiforme
oncogenomics and signaling pathways. Clin Med Oncol. 3:39–52.
2009.PubMed/NCBI
|
|
3
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:192018. View Article : Google Scholar
|
|
4
|
Wang H, Zhang H, Zeng J and Tan Y: ceRNA
network analysis reveals prognostic markers for glioblastoma. Oncol
Lett. 17:5545–5557. 2019.PubMed/NCBI
|
|
5
|
Dragomir M, Mafra ACP, Dias SMG, Vasilescu
C and Calin GA: Using microRNA networks to understand cancer. Int J
Mol Sci. 19:192018. View Article : Google Scholar
|
|
6
|
Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer
A, Llobet-Navas D, Rajbhandari P, Bansal M, Guarnieri P, Silva J,
et al: An extensive microRNA-mediated network of RNA-RNA
interactions regulates established oncogenic pathways in
glioblastoma. Cell. 147:370–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cui L, Li Y, Lv X, Li J, Wang X, Lei Z and
Li X: Expression of MicroRNA-301a and its functional roles in
malignant melanoma. Cell Physiol Biochem. 40:230–244. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng LN, Shi WT, Feng HR, Wei CY and Yin
QN: Effect of miR-301a/PTEN pathway on the proliferation and
apoptosis of cervical cancer. Innate Immun. 25:217–223. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi W, Gerster K, Alajez NM, Tsang J,
Waldron L, Pintilie M, Hui AB, Sykes J, P'ng C, Miller N, et al:
MicroRNA-301 mediates proliferation and invasion in human breast
cancer. Cancer Res. 71:2926–2937. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia X, Zhang K, Luo G, Cen G, Cao J, Huang
K and Qiu Z: Downregulation of miR-301a-3p sensitizes pancreatic
cancer cells to gemcitabine treatment via PTEN. Am J Transl Res.
9:1886–1895. 2017.PubMed/NCBI
|
|
11
|
Zhang L, Zhang Y, Zhu H, Sun X, Wang X, Wu
P and Xu X: Overexpression of miR-301a-3p promotes colorectal
cancer cell proliferation and metastasis by targeting deleted in
liver cancer-1 and runt-related transcription factor 3. J Cell
Biochem. 120:6078–6089. 2019. View Article : Google Scholar
|
|
12
|
Xia X, Zhang K, Cen G, Jiang T, Cao J,
Huang K, Huang C, Zhao Q and Qiu Z: MicroRNA-301a-3p promotes
pancreatic cancer progression via negative regulation of SMAD4.
Oncotarget. 6:21046–21063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yue X, Cao D, Lan F, Pan Q, Xia T and Yu
H: MiR-301a is activated by the Wnt/β-catenin pathway and promotes
glioma cell invasion by suppressing SEPT7. Neuro Oncol.
18:1288–1296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He L, Zhou H, Zeng Z, Yao H, Jiang W and
Qu H: Wnt/β-catenin signaling cascade: A promising target for
glioma therapy. J Cell Physiol. 234:2217–2228. 2019. View Article : Google Scholar
|
|
15
|
Zhang K, Zhang J, Han L, Pu P and Kang C:
Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol.
7:740–749. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic Modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zebisch M, Xu Y, Krastev C, MacDonald BT,
Chen M, Gilbert RJ, He X and Jones EY: Structural and molecular
basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by
the Wnt agonist R-spondin. Nat Commun. 4:27872013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiao G, Dai C, He Y, Shi J and Xu C:
Effects of miR 106b 3p on cell proliferation and epithelial
mesenchymal transition, and targeting of ZNRF3 in esophageal
squamous cell carcinoma. Int J Mol Med. 43:1817–1829.
2019.PubMed/NCBI
|
|
19
|
Shi J, Jiang X, Yu Z, He G, Ning H, Wu Z,
Cai Y, Yu H and Chen A: ZNRF3 contributes to the growth of lung
carcinoma via inhibiting Wnt/β-catenin pathway and is regulated by
miR-93. Tumour Biol. 37:3051–3057. 2016. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Sun J, Jia Z, Li B, Zhang A, Wang G, Pu P,
Chen Z, Wang Z and Yang W: MiR-19 regulates the proliferation and
invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling.
Oncotarget. 8:110785–110796. 2017. View Article : Google Scholar
|
|
22
|
Gebert LFR and MacRae IJ: Regulation of
microRNA function in animals. Nat Rev Mol Cell Biol. 20:21–37.
2019. View Article : Google Scholar :
|
|
23
|
Karimi N, Ali Hosseinpour Feizi M,
Safaralizadeh R, Hashemzadeh S, Baradaran B, Shokouhi B and
Teimourian S: Serum overexpression of miR-301a and miR-23a in
patients with colorectal cancer. J Chin Med Assoc. 82:215–220.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng JZ, Huang YN, Yao L, Liu YR, Liu S,
Hu X, Liu ZB and Shao ZM: Elevated miR-301a expression indicates a
poor prognosis for breast cancer patients. Sci Rep. 8:22252018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD: Association
of MicroRNA expression in hepatocellular carcinomas with hepatitis
infection, cirrhosis, and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner
MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ and Schmittgen
TD: Expression profiling identifies microRNA signature in
pancreatic cancer. Int J Cancer. 120:1046–1054. 2007. View Article : Google Scholar
|
|
27
|
Lan F, Qing Q, Pan Q, Hu M, Yu H and Yue
X: Serum exosomal miR-301a as a potential diagnostic and prognostic
biomarker for human glioma. Cell Oncol (Dordr). 41:25–33. 2018.
View Article : Google Scholar
|
|
28
|
Hao HX, Xie Y, Zhang Y, Charlat O, Oster
E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H, et al: ZNRF3
promotes Wnt receptor turnover in an R-spondin-sensitive manner.
Nature. 485:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Madan B and Virshup DM: Targeting Wnts at
the source - new mechanisms, new biomarkers, new drugs. Mol Cancer
Ther. 14:1087–1094. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Wang Y, Ren H, Jin Y and Guo Y:
ZNRF3 inhibits the invasion and tumorigenesis in nasopharyngeal
carcinoma cells by inactivating the Wnt/β-catenin pathway. Oncol
Res. 25:571–577. 2017. View Article : Google Scholar
|
|
31
|
Yue X, Lan F and Xia T: Hypoxic glioma
cell-secreted exosomal miR-301a activates Wnt/beta-catenin
signaling and promotes radiation resistance by targeting TCEAL7.
Mol Ther. 27:1939–1949. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li X, Zhong M, Wang J, Wang L, Lin Z, Cao
Z, Huang Z, Zhang F, Li Y, Liu M, et al: miR-301a promotes lung
tumorigenesis by suppressing Runx3. Mol Cancer. 18:992019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun J, Li B, Jia Z, Zhang A, Wang G, Chen
Z, Shang Z, Zhang C, Cui J and Yang W: RUNX3 inhibits glioma
survival and invasion via suppression of the β-catenin/TCF-4
signaling pathway. J Neurooncol. 140:15–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu H, Zhang Q, Chen W, Wu T, Liu S, Li X,
Luo B, Zhang T, Yan G, Lu H, et al: MicoRNA-301a promotes
pancreatic cancer invasion and netastasis through the JAK/STAT3
signaling pathway by targeting SOCS5. Carcinogenesis. 41:502–514.
2020. View Article : Google Scholar
|
|
35
|
Lu Z and Li Y, Takwi A, Li B, Zhang J,
Conklin DJ, Young KH, Martin R and Li Y: miR-301a as an NF-κB
activator in pancreatic cancer cells. EMBO J. 30:57–67. 2011.
View Article : Google Scholar
|
|
36
|
Yin J, Chen D, Luo K, Lu M, Gu Y, Zeng S,
Chen X, Song Y, Zhang Z, Zheng G, et al: Cip2a/miR-301a feedback
loop promotes cell proliferation and invasion of triple-negative
breast cancer. J Cancer. 10:5964–5974. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bracken CP, Scott HS and Goodall GJ: A
network-biology perspective of microRNA function and dysfunction in
cancer. Nat Rev Genet. 17:719–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Besharat ZM, Abballe L, Cicconardi F,
Bhutkar A, Grassi L, Le Pera L, Moretti M, Chinappi M, D'Andrea D,
Mastronuzzi A, et al: Foxm1 controls a pro-stemness microRNA
network in neural stem cells. Sci Rep. 8:35232018. View Article : Google Scholar : PubMed/NCBI
|
